Guide to Hematocrit
Summary
Hematocrit is the percentage of your total blood volume that is made up of red blood cells. The remaining portion consists primarily of plasma, the liquid component of blood.
Why It Matters
Red blood cells contain hemoglobin, the protein that binds oxygen in the lungs and releases it to tissues throughout the body. Hematocrit serves as an indicator of your blood's oxygen-carrying capacity and your body's ability to deliver oxygen to tissues and organs.
When hematocrit is too low (anemia), tissues may not receive adequate oxygen. Conversely, when hematocrit is too high (polycythemia), blood becomes more viscous and may not flow properly through small blood vessels, potentially increasing the risk of clots and stroke or heart attack.
Your hematocrit level helps diagnose various conditions, including anemia, polycythemia, dehydration, and bleeding disorders. It also serves as a monitoring tool for evaluating responses to treatments for these conditions and for assessing the impact of certain medications on red blood cell production.
Hemocrit can be influenced by acute conditions like blood loss or chronic diseases. So while a single hematocrit measurement provides valuable information, trends over time often offer more insight than isolated readings, particularly when monitoring chronic conditions or treatment effectiveness.
Associated Symptoms
Hematocrit levels are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health conditions, each with its own symptoms. It is important to note that many symptoms (such as fatigue and dizziness) are nonspecific and can overlap with other conditions. Your doctor will always interpret hematocrit in the context of other tests.
Common symptoms that may indicate conditions associated with low hematocrit (anemia):
- Melena (black-colored stool): may be seen in an upper GI bleed
- Fatigue and weakness: Can occur when reduced oxygen delivery to tissues impairs cellular energy production and muscle function
- Shortness of breath: May reflect the body compensating for reduced oxygen-carrying capacity by increasing respiratory rate, particularly during physical activity
- Dizziness or lightheadedness: May occur when decreased oxygen delivery to the brain affects neurological function
- Pale skin, nail beds, and mucous membranes: Reduced red blood cell content in small blood vessels can cause visible pallor
- Cold hands and feet: May be due to poor circulation and reduced oxygen delivery to extremities
- Rapid or irregular heartbeat: May result from the heart pumping faster to compensate for reduced oxygen-carrying capacity
Common symptoms that may indicate conditions associated with high hematocrit (polycythemia):
- Visual disturbances: Reduced blood flow through retinal vessels may be due to increased blood viscosity
- Facial flushing or ruddy complexion: May result from increased red blood cell concentration in facial blood vessels
- Hypertension: Increased blood volume and viscosity can elevate blood pressure
- Itchy skin: Often worse after warm showers, can be related to histamine release from increased mast cells
- Easy bruising or bleeding: Paradoxically, high red cell count can disrupt normal clotting mechanisms
- Joint pain: Often affects hands and feet, may be related to microcirculatory changes or crystal formation
It's important to understand that many factors can cause these symptoms, and hematocrit levels are just one piece of diagnostic information. The presence of symptoms alongside abnormal hematocrit provides context for further investigation, but additional testing is typically needed to determine the underlying cause.
Clinical Ranges
Female:
- ≤18 Years: 34.0-46.0%
- >18 Years: 35.0-45.0%
Male:
- ≤18 Years: 36.0-49.0%
- >18 Years: 38.5-50.0%
Lifestyle Factors That Can Impact It
Factors that may decrease hematocrit levels include the following:
- Poor dietary intake of iron, vitamin B12, or folate can lower red blood cell production.
- A vegetarian or vegan diet can lead to iron deficiency.
- Regular blood donation reduces levels through blood loss.
- Heavy menstrual bleeding also reduces levels through blood loss.
Factors that may increase hematocrit levels include the following:
- Living at high altitude increases red cell production.
- Dehydration reduces plasma volume, concentrating red blood cells.
- Smoking causes carbon monoxide exposure, which stimulates red blood cell production.
- Binge drinking can concentrate the blood via dehydration, but long-term heavy use usually lowers hematocrit (through bone marrow suppression, folate deficiencies)
- Performance-enhancing substances (erythropoietin, anabolic steroids) stimulate red blood cell production.
Other Factors That Can Impact It
Medical Conditions
- Kidney disease: Decreases hematocrit through reduced erythropoietin production, the hormone that stimulates red blood cell formation
- Gastrointestinal bleeding: Lowers hematocrit through direct loss of red blood cells
- Hemolytic disorders: Reduce hematocrit by destroying red blood cells faster than they can be replaced
- Bone marrow disorders: Can decrease or increase hematocrit depending on the underlying condition
- Sleep apnea: Can increase hematocrit over time
- Chronic inflammatory conditions: Lower hematocrit through cytokine effects that suppress erythropoiesis
- Pregnancy naturally lowers hematocrit due to increased plasma volume, which is a normal physiological change (hemodilution)
Medications
- Iron supplements: Increase hematocrit by providing essential building blocks for hemoglobin
- Erythropoiesis-stimulating agents: Increase hematocrit by directly stimulating red blood cell production in bone marrow
- Chemotherapy drugs: Decrease hematocrit through suppression of rapidly dividing bone marrow cells
- NSAIDs: Potentially decrease hematocrit through gastrointestinal blood loss if used chronically
- ACE inhibitors and ARBs: May reduce hematocrit in some patients through effects on kidney blood flow and erythropoietin
- Hydroxyurea: Intentionally lowers hematocrit by suppressing the production of red blood cells by bone marrow
Testing Accuracy and Stability
Hematocrit testing is generally reliable. However, hydration can influence results, potentially leading to values that don't accurately reflect your true level.
Factors That Can Affect the Accuracy of Your Test:
- Dehydration falsely increases measured hematocrit by concentrating red cells in reduced plasma volume.
- Recent IV fluid administration decreases measured values through hemodilution.
How it Relates to Other Markers
Your healthcare provider will likely interpret your hematocrit results alongside other blood markers, including:
- Hemoglobin: Hematocrit typically equals about three times the hemoglobin value. Discrepancies can suggest potential measurement errors or unusual red blood cell characteristics.
- Red blood cell count: This marker provides context for whether hematocrit changes reflect altered cell number or size.
- Mean corpuscular volume (MCV): It helps classify anemias---microcytic (small cells), normocytic (normal-sized cells), or macrocytic (large cells).
- Iron studies: Ferritin, transferrin saturation, and iron levels help determine if iron deficiency is contributing to low hematocrit.
- Reticulocyte count: This marker indicates whether bone marrow is responding appropriately to anemia by producing new red cells.
- Inflammatory markers: C-reactive protein and erythrocyte sedimentation rate help identify if inflammation is contributing to anemia of chronic disease.
What Results May Mean in the Context of Other Markers
- Low hematocrit with low MCV and low ferritin: Can indicate iron deficiency anemia; typically responds well to iron supplementation.
- Low hematocrit with high MCV and low B12/folate: May suggest megaloblastic anemia from vitamin deficiency; targeted supplementation usually effective.
- Low hematocrit with normal MCV and elevated inflammatory markers: May suggest anemia of chronic disease; treating underlying condition is the primary approach.
- Low hematocrit with elevated reticulocyte count: Indicates adequate bone marrow response to anemia; may suggest blood loss or hemolysis rather than a production problem.
- High hematocrit with elevated white blood cells and platelets: May indicate myeloproliferative disorder like polycythemia vera; requires hematology evaluation.
- High hematocrit with normal other indices and history of smoking: Can suggest secondary polycythemia from chronic hypoxemia; smoking cessation often improves values.
- Isolated high hematocrit with decreased plasma volume: May represent relative polycythemia from dehydration rather than absolute increase in red cells.
Follow-up Considerations
When hematocrit levels are outside the normal range, your healthcare provider will develop a personalized approach that may include medications, dietary changes, lifestyle modifications, or treatment of underlying conditions. This approach typically involves ongoing monitoring through repeated testing and may include additional diagnostic evaluations to determine the root cause. You should always speak to your doctor if you have medical questions or before making medical decisions.
When Re-Testing May be Appropriate
- Mild abnormalities: Every 3--6 months
- During treatment for anemia: Every 4--8 weeks until normalized
- After medication adjustments: 2--4 weeks to assess response
- Significant abnormalities: Every 2--4 weeks until stable
- Post-normalization monitoring: Every 3--6 months for at least a year
- Chronic conditions requiring long-term monitoring: As directed by provider, typically every 3--12 months
Additional Testing or Monitoring Your Doctor May Consider
- Iron tests
- Vitamin B12 and folate levels
- Renal function tests (blood nitrogen urea, creatinine, glomerular filtration rate)
- Hemoglobin electrophoresis for suspected hemoglobinopathies
- Bone marrow examination in cases of unexplained cytopenias
- Erythropoietin levels for suspected polycythemia
- JAK2 mutation testing for suspected polycythemia vera
- Oxygen saturation and arterial blood gases for suspected hypoxemia
- New onset anemia after age 50 often prompts screening for colorectal cancer or other GI malignancies
When Additional Care May be Warranted
- Hematocrit below 25 percent or above 60 percent
- Rapid decline (>5 percent drop in less than one month)
- Symptoms of severe anemia or hyperviscosity
- No improvement despite appropriate treatment
- Unexplained abnormalities in other blood cell lines
- New onset anemia after age fifty (may require evaluation for gastrointestinal bleeding)
- Significant symptoms even with mild hematocrit abnormalities
- Pregnancy with hematocrit below 30 percent
Bibliography
References
1. DeLoughery, Thomas G. "Microcytic Anemia." New England Journal of Medicine, vol. 371, no. 14, 2014, pp. 1324--1331. doi:10.1056/NEJMra1215361.
2. Mehta, Jayesh, and Seema Singhal. "Hyperviscosity Syndrome in Plasma Cell Dyscrasias." Seminars in Thrombosis and Hemostasis, vol. 29, no. 5, 2003, pp. 467--471. doi:10.1055/s-2003-44554.
3. Tefferi, Ayalew, and Tiziano Barbui. "Polycythemia Vera and Essential Thrombocythemia: 2021 Update on Diagnosis, Risk-Stratification and Management." American Journal of Hematology, vol. 95, no. 12, 2020, pp. 1599--1613. doi:10.1002/ajh.26008.
4. Pasricha, Sant-Rayn, et al. "Iron Deficiency." The Lancet, vol. 397, no. 10270, 2021, pp. 233--248. doi:10.1016/S0140-6736(20)32594-0.
5. Bunn, H. Franklin. "Approach to the Anemias." Goldman-Cecil Medicine, edited by Lee Goldman and Andrew I. Schafer, 26th ed., Elsevier, 2019, pp. 1018--1026.
6. Brittenham, Gary M. "Disorders of Iron Homeostasis: Iron Deficiency and Overload." Hematology: Basic Principles and Practice, edited by Ronald Hoffman et al., 7th ed., Elsevier, 2018.
7. Cappellini, Maria Domenica, et al. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd ed., Thalassaemia International Federation, 2014.




